
Vogey 0.2 Tablet
Marketer
IGP Mediventures Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Vogey 0.2 Tablet
Diabetac 0.2mg tablets are indicated for the management of type 2 diabetes. This medication assists in regulating postprandial hyperglycemia (elevated blood sugar after meals). It's prescribed when dietary modifications and other anti-diabetic agents prove insufficient in achieving glycemic control. Diabetac 0.2mg tablets should be administered immediately prior to meals. Dosage and frequency are to be determined by your physician to optimize blood glucose management. Discontinuation should not occur without prior consultation with your doctor, as abrupt cessation may lead to elevated blood sugar levels, potentially resulting in severe complications such as renal impairment or vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as recommended by your doctor. Regular blood glucose monitoring is essential while using this medication. Commonly reported side effects include abdominal discomfort, flatulence, anorexia, constipation, and diarrhea. Report any persistent or bothersome adverse effects to your doctor. While this medication alone does not typically cause hypoglycemia, concomitant use with other anti-diabetic agents (particularly insulin or sulfonylureas) elevates the risk. Hypoglycemic episodes require treatment with glucose; sucrose is ineffective. Prior to initiating treatment, disclose any renal or hepatic conditions to your physician. This medication is contraindicated in patients with active bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals should consult their physician before use. Complete disclosure of all other medications is crucial for safe usage. Limit alcohol consumption as it can potentially increase the risk of hypoglycemia.
Primary Ingredients of Vogey 0.2 Tablet
No text was provided to rewrite.
Uses of Vogey 0.2 Tablet
Managing type 2 diabetes
Major Benefits of Vogey 0.2 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vogey 0.2 Tablet on an empty stomach.
Common Side effects of Vogey 0.2 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogey 0.2 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vogey 0.2 Tablet on an empty stomach.
How Vogey 0.2 Tablet works:
Vogey 0.2mg tablets are used to manage diabetes. Their mechanism of action involves blocking intestinal enzymes that digest complex carbohydrates, thus reducing postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogey 0.2 Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Vogey 0.2 Tablet during pregnancy is generally deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Vogey 0.2 Tablet while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vogey 0.2 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Vogey 0.2 Tablet cautiously. Dosage modification of Vogey 0.2 Tablet might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Vogey 0.2 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vogey 0.2 Tablet :
Omit any missed Vogey 0.2 Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Vogey 0.2 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
